BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24755877)

  • 21. Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.
    Allen C; Opyrchal M; Aderca I; Schroeder MA; Sarkaria JN; Domingo E; Federspiel MJ; Galanis E
    Gene Ther; 2013 Apr; 20(4):444-9. PubMed ID: 22914495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.
    Kanai R; Rabkin SD; Yip S; Sgubin D; Zaupa CM; Hirose Y; Louis DN; Wakimoto H; Martuza RL
    J Natl Cancer Inst; 2012 Jan; 104(1):42-55. PubMed ID: 22173583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells.
    Liu RY; Zhou L; Zhang YL; Huang BJ; Ke ML; Chen JM; Li LX; Fu X; Wu JX; Huang W
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):171-6. PubMed ID: 24269822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
    Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
    Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.
    Bai Y; Lathia JD; Zhang P; Flavahan W; Rich JN; Mattson MP
    Glia; 2014 Oct; 62(10):1687-98. PubMed ID: 24909307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T; Ren C; Ponnazhagan S
    Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
    Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
    J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
    Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
    Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
    Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
    Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
    Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
    Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors.
    Sun X; Qiao H; Jiang H; Zhi X; Liu F; Wang J; Liu M; Dong D; Kanwar JR; Xu R; Krissansen GW
    Cancer Gene Ther; 2005 Jan; 12(1):35-45. PubMed ID: 15486558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method.
    Kim KS; Park YS
    Oncol Res; 2005; 15(7-8):343-50. PubMed ID: 16491952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
    Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML
    PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice.
    Chen QR; Kumar D; Stass SA; Mixson AJ
    Cancer Res; 1999 Jul; 59(14):3308-12. PubMed ID: 10416583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
    Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
    Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes.
    Kim KS; Kim HS; Park JS; Kwon YG; Park YS
    Cancer Gene Ther; 2004 Jun; 11(6):441-9. PubMed ID: 15118757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.